PPBT

Purple Biotech Ltd.

There isn't enough reported data to score PPBT yet.

PPBT Fundamentals

MetricStatus
Unavailable
Stable
Unavailable
Unavailable

PPBT's profitability is currently stable. There isn't enough data to rate its revenue, cash flow and balance sheet.

PPBT PE Valuation

PPBT has no meaningful PE right now: it lost money over the past year.

PPBT Forward outlook

There aren't enough analyst estimates for PPBT to show an outlook.

PPBT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.56 on Nov 12.

There is not enough scenario data to assess PPBT's risk to reward.

PPBT Earnings Per Share

Q4 2021: $-21.04Q1 2022: $-21.70Q2 2022: $-21.50Q3 2022: $-23.26Q4 2022: $-24.02Q1 2023: $-20.74Q2 2023: $-21.70Q3 2023: $-20.98Q4 2023: $-18.22Q4 2024: $49.90Q4 2025: $0.03
Q4 2021: $-21.04Q1 2022: $-21.70Q2 2022: $-21.50Q3 2022: $-23.26Q4 2022: $-24.02Q1 2023: $-20.74Q2 2023: $-21.70Q3 2023: $-20.98Q4 2023: $-18.22Q4 2024: $49.90Q4 2025: $0.03
QuarterTTM EPSYoY
Q4 2025$0.03-100%
Q4 2024$49.90+$68.12
Q4 2023-$18.22+$5.80
Q3 2023-$20.98+$2.28
Q2 2023-$21.70-$0.20
Q1 2023-$20.74+$0.96
Q4 2022-$24.02-$2.98
Q4 2021-$21.04-104%

PPBT has returned to profit: it earned $0.03 per share over the past year, after losing money the year before.

PPBT Quarterly Revenue

Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q4 2024: --Q4 2025: --
Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q4 2024: --Q4 2025: --
QuarterRevenueYoY
Q2 2019$1M0%

PPBT's revenue is shrinking: $0 last quarter.

PPBT Free Cash Flow

Q3 2021: −$3MQ4 2021: −$4MQ1 2022: −$5MQ2 2022: −$4MQ3 2022: −$4MQ4 2022: −$4MQ1 2023: −$6MQ2 2023: −$5MQ3 2023: −$4MQ4 2023: −$5MQ4 2024: --Q4 2025: −$6M
Q3 2021: −$3MQ4 2021: −$4MQ1 2022: −$5MQ2 2022: −$4MQ3 2022: −$4MQ4 2022: −$4MQ1 2023: −$6MQ2 2023: −$5MQ3 2023: −$4MQ4 2023: −$5MQ4 2024: --Q4 2025: −$6M
QuarterFree cash flowYoY
Q4 2023-$5M-$768K
Q3 2023-$3.7M-$29K
Q2 2023-$5.2M-$1.5M
Q1 2023-$6.1M-$650K
Q4 2022-$4.2M-$461K
Q3 2022-$3.6M-$680K
Q2 2022-$3.7M+$1.5M
Q1 2022-$5.4M-$1.9M

PPBT has burned cash in almost every quarter: −$20M over the past year, against −$18M the year before.

PPBT Total Shares

Q3 2021: 875,610Q4 2021: 877,005Q1 2022: 890,630Q2 2022: 899,085Q3 2022: 903,665Q4 2022: 919,460Q1 2023: 991,930Q2 2023: 1MQ3 2023: 1MQ4 2023: 1MQ4 2024: 163,979
Q3 2021: 875,610Q4 2021: 877,005Q1 2022: 890,630Q2 2022: 899,085Q3 2022: 903,665Q4 2022: 919,460Q1 2023: 991,930Q2 2023: 1MQ3 2023: 1MQ4 2023: 1MQ4 2024: 163,979
PeriodChange %Net change
Quarterly-87%-1.1M shares
1 year-83%-828K shares
3 years-81%-705K shares

PPBT has 163,979 diluted shares, down 83% from a year ago.

PPBT Net Leverage

PPBT Weekly Momentum

MetricValueStatus
RSI36.9Neutral
Stochastic26.0Neutral

PPBT's weekly RSI is 37 (neutral) and its Stochastic is 26 (neutral).

PPBT PE vs Healthcare Sector

MetricPPBTSector medianRelative
PEN/A26x—

PPBT has no meaningful PE right now: it lost money over the past year.

PPBT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.3317% above
20 week MA$1.466.8% above
50 week MA$3.4755% below
100 week MA$12.988% below
200 week MA$105.099% below

PPBT has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 99% below its 200-week average.

PPBT Yearly ROI

YearStart priceEnd priceROI
2020$1,519.8$826.0-46%
2021$826.0$842.0+1.9%
2022$842.0$316.0-62%
2023$316.0$156.0-51%
2024$156.0$43.6-72%
2025$43.6$7.06-84%
2026 YTD$7.06$1.56-78%

PPBT has finished four years in a row lower, and it's down 78% so far in 2026.

Give your agent the market.

Get API key